Barclays PLC Amphastar Pharmaceuticals, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Barclays PLC holds 84,790 shares of AMPH stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,790

Previous 74,456 13.88%

Holding current value

$2.41 Million

Previous $3.61 Million 12.87%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$36.84 - $53.4 $380,704 - $551,835	10,334 Added 13.88%	84,790 $3.15 Million
Q3 2024 Nov 15, 2024	BUY	$36.99 - $50.09 $957,227 - $1.3 Million	25,878 Added 53.27%	74,456 $3.61 Million
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $860,117 - $967,603	-22,254 Reduced 31.42%	48,578 $1.94 Million
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $325,231 - $481,585	7,590 Added 12.0%	70,832 $3.11 Million
Q4 2023 Feb 15, 2024	BUY	$44.49 - $62.93 $1.76 Million - $2.48 Million	39,449 Added 165.8%	63,242 $3.91 Million
Q3 2023 Nov 07, 2023	SELL	$45.51 - $65.0 $294,176 - $420,160	-6,464 Reduced 21.36%	23,793 $1.09 Million
Q2 2023 Aug 03, 2023	SELL	$35.77 - $58.38 $395,508 - $645,507	-11,057 Reduced 26.76%	30,257 $1.74 Million
Q1 2023 May 04, 2023	SELL	$27.99 - $37.92 $605,031 - $819,678	-21,616 Reduced 34.35%	41,314 $1.55 Million
Q4 2022 Feb 13, 2023	BUY	$27.93 - $31.27 $207,408 - $232,211	7,426 Added 13.38%	62,930 $1.76 Million
Q3 2022 Nov 03, 2022	SELL	$27.56 - $37.75 $237,401 - $325,178	-8,614 Reduced 13.43%	55,504 $1.56 Million
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $350,717 - $497,880	11,773 Added 22.49%	64,118 $2.23 Million
Q1 2022 May 16, 2022	SELL	$22.96 - $36.45 $484,111 - $768,548	-21,085 Reduced 28.71%	52,345 $1.88 Million
Q4 2021 Feb 14, 2022	BUY	$18.14 - $23.29 $174,379 - $223,886	9,613 Added 15.06%	73,430 $1.71 Million
Q3 2021 Nov 09, 2021	BUY	$17.83 - $21.49 $323,275 - $389,635	18,131 Added 39.69%	63,817 $1.21 Million
Q2 2021 Aug 13, 2021	SELL	$17.11 - $20.92 $503,564 - $615,696	-29,431 Reduced 39.18%	45,686 $921,000
Q1 2021 May 13, 2021	BUY	$17.21 - $20.65 $38,361 - $46,028	2,229 Added 3.06%	75,117 $1.38 Million
Q4 2020 Feb 11, 2021	BUY	$17.76 - $21.24 $72,975 - $87,275	4,109 Added 5.97%	72,888 $1.47 Million
Q3 2020 Nov 12, 2020	BUY	$17.99 - $22.22 $228,670 - $282,438	12,711 Added 22.67%	68,779 $1.29 Million
Q2 2020 Aug 12, 2020	BUY	$14.25 - $22.46 $182,300 - $287,330	12,793 Added 29.56%	56,068 $1.26 Million
Q1 2020 May 13, 2020	SELL	$12.66 - $20.08 $147,944 - $234,654	-11,686 Reduced 21.26%	43,275 $642,000
Q4 2019 Feb 10, 2020	BUY	$17.07 - $20.64 $299,817 - $362,520	17,564 Added 46.97%	54,961 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $22.62 $76,556 - $90,570	-4,004 Reduced 9.67%	37,397 $742,000
Q2 2019 Aug 14, 2019	BUY	$18.92 - $22.96 $195,859 - $237,681	10,352 Added 33.34%	41,401 $873,000
Q1 2019 May 15, 2019	BUY	$19.46 - $25.28 $345,084 - $448,290	17,733 Added 133.17%	31,049 $634,000
Q4 2018 Feb 14, 2019	SELL	$17.72 - $22.51 $439,385 - $558,157	-24,796 Reduced 65.06%	13,316 $265,000
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $305,075 - $384,169	19,823 Added 108.39%	38,112 $733,000
Q2 2018 Aug 14, 2018	BUY	$14.63 - $19.6 $11,104 - $14,876	759 Added 4.33%	18,289 $278,000
Q1 2018 May 15, 2018	BUY	$17.23 - $20.35 $202,383 - $239,031	11,746 Added 203.08%	17,530 $328,000
Q4 2017 Feb 14, 2018	BUY	$17.76 - $19.75 $87,769 - $97,604	4,942 Added 586.94%	5,784 $112,000
Q3 2017 Nov 14, 2017	BUY	$14.73 - $17.99 $12,402 - $15,147	842	842 $15,000

Others Institutions Holding AMPH

# of Institutions

275

Shares Held

35.2M

Call Options Held

26.5K

Put Options Held

7.9K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.39B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account